Lemon balm supplement tested for stress relief in new study
NCT ID NCT06942897
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This pilot study tests whether a daily lemon balm supplement can improve mood and reduce stress in healthy adults. Forty volunteers will take either the supplement or a placebo for 3 weeks. Researchers will measure changes in stress perception and cortisol levels.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Melissa officinalis (lemon balm) extract formulated in phospholipids
- What this could lead to
- If it works, this could point toward a natural supplement to help manage everyday stress and improve mood.
- What could go wrong
- This is a very small, early pilot study with only 40 healthy adults over 3 weeks. Results may not apply to people with stress disorders or long-term use.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 40 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
Jun 2026
An estimate. Start dates often move.
- Expected to finish
-
Sep 2026
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 65 years
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Age between 18 and 65 years * Healthy volunteers as assessed by medical history and physical examination * Willingness to comply with the study procedures Exclusion Criteria: * Current use of medications or supplements that may affect mood or cortisol levels * Known allergy or sensitivity to Melissa officinalis or phospholipids * History of psychiatric disorders (e.g., major depression, anxiety disorders) * Significant comorbidities (e.g., cardiovascular, hepatic, renal diseases) * Pregnant or breastfeeding women * Participation in another clinical trial in the past 30 days
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Emotional well-being are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The official record
The full official record for this study. This one lists no contact details, but it is the first place any would appear.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can exercising with your baby reshape postpartum recovery?
- Can a brain scan and your phone predict where depression goes next?
- Wearables and a secure platform: can digital health reach remote patients and space?
- Can yoga and mindfulness lift the fog of postpartum depression?
- Can free groceries and classes rewire daily health habits?
- Can a rewired EMDR therapy ease the mental toll of migration?